Category Archives: Nephrology

Hydroxyethyl Starch Solutions FDA Safety Communication

Share

Hydroxyethyl Starch Solutions: FDA Safety Communication – Boxed Warning on Increased Mortality and Severe Renal Injury and Risk of Bleeding   AUDIENCE: Critical Care Medicine, Nephrology, Patient, Pharmacy, Health Professional ISSUE: FDA has analyzed recent data that indicate an increased … Continue reading

Share
Posted in Critical Care Medicine, FDA 2013, FDA Safety Communication, Healthcare Professionals, Nephrology, Patients, Pharmacy | Tagged , , , , , , , , , | Comments Off on Hydroxyethyl Starch Solutions FDA Safety Communication

Samsca tolvaptan Drug Warning

Share

Samsca (tolvaptan): Drug Warning – Potential Risk of Liver Injury AUDIENCE: Gastroenterology, Nephrology, Pharmacy ISSUE: Otsuka and FDA notified healthcare professionals of significant liver injury associated with the use of Samsca. In a double-blind, 3-year, placebo-controlled trial in about 1400 … Continue reading

Share
Posted in FDA 2013, FDA Warning, Gastroenterology, Nephrology, Pharmacy | Tagged , , , , , , , , , , | Comments Off on Samsca tolvaptan Drug Warning

Cefepime Label Change drug risks

Share

Cefepime:Label Change- Risk of Seizure in Patients Not Receiving Dosage Adjustments for Kidney Impairment   Audience: Health Professional,Infectious Disease, Nephrology Issue: There have been cases of a specific type of seizure called nonconvulsive status epilepticus associated with the use of … Continue reading

Share
Posted in FDA 2012, FDA Warning, Healthcare Professionals, Infectious Disease, Nephrology | Tagged , , , , , , , , , , , | Comments Off on Cefepime Label Change drug risks

Dialysate Concentrates Used in Hemodialysis Safety Communication

Share

Dialysate Concentrates Used in Hemodialysis: Safety Communication – Alkali Dosing Errors AUDIENCE: Nephrology, Nursing ISSUE: FDA is notifying health care providers to consider the presence and quantity of acetate, citrate, and/or acetic acid in dialysate concentrates when determining the patients’ … Continue reading

Share
Posted in FDA 2012, FDA Safety Communication, Nephrology, Nursing | Tagged , , , , , , , | Comments Off on Dialysate Concentrates Used in Hemodialysis Safety Communication